Clicky

Sanofi SA(SAN) News

Date Title
Jun 23 Press Release: Sarclisa recommended for EU approval by the CHMP to treat transplant-eligible newly diagnosed multiple myeloma
Jun 21 Sanofi (ENXTPA:SAN) Gains FDA Approval For Dupixent To Address Rare Skin Disease
Jun 20 Sanofi & Regeneron's Dupixent Gets FDA Nod for Bullous Pemphigoid
Jun 20 DoH – Abu Dhabi and Sanofi link for vaccine development
Jun 20 Press Release: Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid
Jun 17 Verve Therapeutics Stock Soars 76% on $1.3B Buyout Offer From Lilly
Jun 17 Press release: Sanofi successfully prices €1.5 billion bond issue
Jun 16 European Equities Close Mostly Higher in Monday Trading; Renault CEO to Step Down, Expected to Join Kering
Jun 16 5 Large Drug Stocks That Are Poised to Ride on Sector Recovery
Jun 15 Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study
Jun 15 Dupixent® (dupilumab) Demonstrated Superiority Over Xolair® (Omalizumab) in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in Patients with Coexisting Asthma in First-ever Presented Phase 4 Head-to-Head Respiratory Trial
Jun 15 Berenberg Bank Remains a Buy on Sanofi (SNY), Sets a €118 Price Target
Jun 15 Regeneron, Sanofi Announce Positive Dupixent Results for Atopic Dermatitis
Jun 12 Novavax's COVID-Flu Combo Shot Shows Strong Immune Response
Jun 11 Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel
Jun 10 Sanofi (ENXTPA:SAN) Expands Beyfortus RSV Protection Production For Global Demand
Jun 10 Merck Secures FDA Nod for New RSV Antibody Enflonsia in Infants
Jun 9 Sanofi: Information concerning the total number of voting rights and shares - May 2025
Jun 9 Beyfortus Output Tripled As Sanofi, AstraZeneca Scale Up For RSV Season
Jun 9 Regeneron and Sanofi’s dupilumab shows promise in AD trial